Wall Street closes at a record for the first time since end of January
MIDDLETON, MA - SCWorx Corp. (NASDAQ:WORX) announced Monday a new partner agreement with an unnamed healthcare supply chain company that specializes in AI-powered payment process automation. The micro-cap company, currently valued at just $3.13 million, has seen its stock price plummet 88% year-to-date to $0.21, trading near its 52-week low of $0.20, according to InvestingPro data.
According to the press release, the partner company utilizes artificial intelligence to streamline payment processes and supply chain management for healthcare organizations. The platform aims to deliver insights and optimize performance while reducing complexity in operations.
"As a customer and referral partner SCWorx is excited to not only assist the partner with data management service but to also work on new healthcare customer opportunities," said Tim Hannibal, SCWorx CEO.
The agreement aligns with SCWorx’s growth strategy focused on expanding partnerships to increase its market presence. SCWorx provides software-as-a-service data management solutions for healthcare providers, including modules for virtual item management, contract management, data normalization, and analytics.
The company indicated that the partnership would leverage SCWorx’s data management capabilities to support the partner’s technology platform, which focuses on streamlining supply chain and expense management operations.
No financial details of the partnership were disclosed in the announcement.
In other recent news, SCWorx Corp. has secured a 180-day extension from Nasdaq to comply with the minimum bid price requirement. The company now has until April 6, 2026, to meet the $1.00 minimum bid price threshold, after initially being given until October 7, 2025. Additionally, SCWorx announced the renewal of a partnership with an existing healthcare partner for a new three-year term valued at approximately $1,692,000, marking a 113% increase from the previous contract. This renewed agreement involves an expansion in services and a doubling of data processing through SCWorx’s platform. In financial developments, SCWorx entered into warrant inducement agreements, resulting in gross proceeds of approximately $721,574. These agreements involved the exercise of warrants for up to 2,064,000 shares of common stock at an exercise price of $0.3496 per share. The recent developments reflect SCWorx’s efforts to strengthen its financial position and expand its business partnerships.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.